Yi Li

Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL.

Fangfang Wang, Yong Guo, B. Xiang, 2017, The Biochemical journal.

Epigenetic Modifications in Obesity and Type 2 Diabetes

Yi Li, 2022, The Open Biochemistry Journal.

Application of Acyzol in the Context of Zinc Deficiency and Perspectives

G. Aliev, B. Trofimov, L. Parshina, 2019, International journal of molecular sciences.

Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia.

Juan Lin, Yong Guo, Guang-cui He, 2015, The international journal of biochemistry & cell biology.

Issues Related With Calorie Restriction for Prevention and Treatment of Obesity

Yi Li, 2016 .

The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway.

Fangfang Wang, Yong Guo, B. Xiang, 2019, The international journal of biochemistry & cell biology.